NOF and ASBMR partnered to send a comment letter to CMS on the proposed rule updating Medicare Payment under Physician fee Schedule (PFS) (CMS-1751). We also worked on creating a White Paper demonstrating how the FLS model can/should be reimbursed by CMS using the Opioid Usage Disorders (OUD), and subsequently approved additional usage disorders, reimbursement models.
Read MoreSecondary fracture prevention intervention such as fracture liaison services are effective for increasing osteoporosis treatment rates, but are not currently widely used in the United States. We evaluated the cost-effectiveness of secondary fracture prevention intervention after osteoporotic fracture for Medicare beneficiaries.
Read MoreOsteoporosis, or weakening of the bones, is not often included in discussions of major health policy concerns, yet bone fractures due to osteoporosis are responsible for more hospitalizations than heart attacks, strokes or breast cancer. They are also costly.
Read MoreThe Biden-Harris Administration has a tremendous opportunity to save lives and reduce health care costs simply by taking administrative action to incentivize more widespread adoption and use of existing strategies, which have been highly effective in preventing these fractures.
Read MoreThis week, Rep. John B. Larson (CT-01) introduced the Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2021 (H.R. 3517) with Reps. Linda Sánchez (CA-38), Lori Trahan (MA-03), Michael Burgess M.D. (TX-26), and Jackie Walorski (IN-02) to improve access to osteoporosis screening.
Read MoreThe following organizations have submitted a request for the FY22 Labor HHS appropriations bill on behalf of the 54 million Americans with osteoporosis or low bone mass and the two million Medicare beneficiaries who suffer an osteoporotic bone fracture each year.
Read More
